NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹213 Cr | ₹163 Cr | ₹173 Cr | ₹125 Cr | ₹81 Cr |
What is the latest Total Current Assets ratio of NGL FINECHEM ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹213 Cr |
Mar2023 | ₹163 Cr |
Mar2022 | ₹173 Cr |
Mar2021 | ₹125 Cr |
Mar2020 | ₹81 Cr |
How is Total Current Assets of NGL FINECHEM Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹213 Cr | 30.75 | |
Mar2023 | ₹163 Cr | -6.25 | |
Mar2022 | ₹173 Cr | 39.32 | |
Mar2021 | ₹125 Cr | 54.00 | |
Mar2020 | ₹81 Cr | - |
Compare Total Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹894.1 Cr | 8.8% | 41.6% | -47.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 8.8% |
41.6% |
-47.2% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses